Markets

  1. Home
Market Nav

RATIO ANALYSIS

You can view the ratio analysis for the last 5 years.
Kabra Drugs Ltd.
GO
ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue10.0010.0010.0010.0010.00
      
PER SHARE RATIOS     
      
Basic EPS (Rs.)-0.99-1.66-0.77-0.42-0.41
Diluted EPS (Rs.)-0.99-1.66-0.77-0.42-0.41
Cash EPS (Rs.)-0.45-1.68-0.76-0.39-0.33
Book Value[Excl.RevalReserv]/Share (Rs.)10.40-3.34-1.67-0.89-0.47
Book Value[Incl.RevalReserv]/Share (Rs.)10.40-3.34-1.67-0.89-0.47
PBDIT / Share (Rs.)-0.45-1.68-0.76-0.39-0.33
PBIT / Share (Rs.)-0.45-1.68-0.76-0.42-0.41
PBT / Share (Rs.)-0.45-1.68-0.76-0.42-0.41
Net Profit / Share (Rs.)-0.45-1.68-0.76-0.42-0.41
Return on Networth / Equity (%)-4.400.000.000.000.00
Return on Capital Employeed (%)-4.40-67.9746.2247.1586.65
Return On Assets (%)-4.30-16.10-48.02-25.40-12.83
Total Debt / Equity (X)0.01-1.16-1.89-2.61-4.33
      
LIQUIDITY RATIOS     
      
Current Ratio (X)43.841.300.470.620.85
Quick Ratio (X)43.841.300.470.620.85
      
VALUATION RATIOS     
      
Enterprise Value (Cr.)5.412.193.823.022.87
EV / EBITDA (X)-5.02-2.98-11.32-17.22-19.29
Price / BV (X)1.07-2.15-3.35-5.08-9.53
EarningsYield-0.04-0.23-0.13-0.09-0.09
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)PR
FaceValue10.00
  
PER SHARE RATIOS 
Basic EPS (Rs.)-0.99
Diluted EPS (Rs.)-0.99
Cash EPS (Rs.)-0.45
Book Value[Excl.RevalReserv]/Share (Rs.)10.40
Book Value[Incl.RevalReserv]/Share (Rs.)10.40
PBDIT / Share (Rs.)-0.45
PBIT / Share (Rs.)-0.45
PBT / Share (Rs.)-0.45
Net Profit / Share (Rs.)-0.45
Return on Networth / Equity (%)-4.40
Return on Capital Employeed (%)-4.40
Return On Assets (%)-4.30
Total Debt / Equity (X)0.01
LIQUIDITY RATIOS 
Current Ratio (X)43.84
Quick Ratio (X)43.84
VALUATION RATIOS 
Enterprise Value (Cr.)5.41
EV / EBITDA (X)-5.02
Price / BV (X)1.07
EarningsYield-0.04